LEADER 01015nam0-2200349-#-450-
001 990001074520203316
005 20020503114447.0
010   $a0-566-08382-5
035   $a000107452
035   $aUSA01000107452
035   $a(ALEPH)000107452USA01
035   $a000107452
100   $a20020503d2000----km-y0enga50------ba
101 0 $aeng
102   $aUS
105   $ay|||z|||001yy
200 1 $aAshgate Handbook of antineoplastic agents$fedited by G.W.A. Milne
210   $aBurlington$cAshgate$dcopyr. 2000
215   $aXX, 170 p.$d24 cm
606 0 $aChemioterapici
606   $aCancro$xChemioterapia
676   $a616.994061
700  1$aMILNE,$bG.W.A.$0553682
801  0$aIT$bSalbc$cISBD
912   $a990001074520203316
951   $a616.994061 ASH$b2991 far$c616.994061$d00081252
959   $aBK
969   $afar
979   $aCHIARA$b90$c20020503$lUSA01$h1144
979   $aPATRY$b90$c20040406$lUSA01$h1714
996   $aAshgate Handbook of antineoplastic agents$9979371
997   $aUNISA